Dr Michelle Tempest and Dr Niklas Jahn of Candesic diagnose the investment case for the orthopaedic hip and knee joint replacement market.
Candesic is a leading strategy consultancy
head-quartered in London, serving private operators, investors, and public sector organisations.
Candesic at the Goetzpartners COMPASS Symposium 2022
goetzpartners has invited Dr Leonid Shapiro to the COMPASS Symposium 2022, co- hosted by NTT DATA DACH and Baker McKenzie Deutschland.
Your health in your hands
Candesic's Joe Taylor takes on the hot topic of #implantables. Many of you will know that Joe has the "implantable super power" of paying with his hand and here discusses how such technology is disrupting healthcare. Hat tip to Anna Luisa Schaffgotsch at Impli Limited.
Digital clinical trials a new era
Dr Michelle Tempest, Partner and George Holden from Candesic are excited to share their thoughts on 'digital clinical trials'. The silver lining of Covid19 has been to show the power of working together to collect real world evidence - special thanks to all people (patients and NHS staff) involved in the REACT study. This article deep dives into some of the companies who are going global to recruit people and improving the capability of trial data to have diversity. We believe the success of digital clinical trials relies upon the coming together of so many groups of people and hence…
© Candesic 2022